Evidence map›Paper›PMID 32797198›Full record

SynthesisInvestigative ophthalmology & visual science2020

Clinical and Prodromal Ocular Symptoms in Coronavirus Disease: A Systematic Review and Meta-Analysis.

Takenori Inomata, Koji Kitazawa, Toshiki Kuno, Jaemyoung Sung, Masahiro Nakamura, Masao Iwagami, Hisato Takagi, Akie Midorikawa-Inomata, Jun Zhu, Keiichi Fujimoto and 8 more

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Investigative ophthalmology & visual science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 7 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 7 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Hearing Loss, Tinnitus, and Dizziness in COVID-19: A Systematic Review and Meta-Analysis.The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques · 2022
    Pooled it
  5. Pooled it
  6. COVID 19 repercussions in ophthalmology: a narrative review.Sao Paulo medical journal = Revista paulista de medicina
    Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 3 countries.

Takenori InomataDepartment of Ophthalmology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Koji KitazawaDepartment of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Toshiki KunoDepartment of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, New York, United States.
Jaemyoung SungDepartment of Ophthalmology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Masahiro NakamuraDepartment of Digital Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Masao IwagamiDepartment of Health Services Research, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Hisato TakagiDepartment of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan.
Akie Midorikawa-InomataDepartment of Hospital Administration, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Jun ZhuDepartment of Ophthalmology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Keiichi FujimotoDepartment of Ophthalmology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Yuichi OkumuraDepartment of Strategic Operating Room Management and Improvement, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Maria MiuraDepartment of Digital Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Kenta FujioDepartment of Digital Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Kunihiko HirosawaDepartment of Digital Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yasutsugu AkasakiDepartment of Digital Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Mizu KuwaharaDepartment of Digital Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Reza DanaMassachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States.
Akira MurakamiDepartment of Ophthalmology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Juntendo University · JPJuntendo University Hospital · JPHarvard University · USKyoto Prefectural University of Medicine · JPMount Sinai Beth Israel · USShizuoka Medical Center · JPUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This systematic review aimed to determine currently reported clinical and prodromal ocular symptoms in patients with coronavirus disease 2019 (COVID-19). Methods: An online article search was performed in PubMed and EMBASE. Altogether 15 studies (retrospective, prospective, or case studies) involving 1533 patients with COVID-19, reporting on ocular symptoms, and with outcome data available were identified. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guidelines were followed. Study-specific estimates (incidence rates of ocular symptoms in patients with COVID-19) of cases were combined using one-group meta-analysis in a random-effects model. Results: Of all included studies, 11.2% (95% confidence interval, 5.5-16.9; 78/1526 cases) reported ocular symptoms. The most common ocular finding was conjunctivitis. Prodromal ocular symptoms occurred in 12.5% (13/104 cases) of patients with COVID-19. Positive real-time polymerase chain reaction results were obtained for 16.7% (10/60 cases) of conjunctival samples and 0% (0/17 cases) of tear samples. Twelve ocular conjunctival swab samples tested positive for SARS-CoV-2. Ten cases were from subjects showing ocular symptoms (16.7%, 10/60 cases), and the remaining two cases were from subjects without ocular manifestation (1.8%, 2/113 cases). Limitations included the short study period, small sample size, findings were limited to the Asian population, only seven articles included ophthalmologic examination details, and there is currently no consensus on COVID-19 management. Conclusions: Ocular symptoms may occur in the presymptomatic phase as a prodromal symptom (12.5%, 13/104 cases), suggesting the possibility of viral transmission from the conjunctiva.

Indexed as

Prodromal SymptomsClinical Laboratory TechniquesConjunctivitis, ViralCoronavirus InfectionsCOVID-19COVID-19 TestingDisease ProgressionDNA, ViralFemaleHumansIncidenceMalePandemicsPneumonia, ViralPrognosisReal-Time Polymerase Chain ReactionDNA, Viral

Identifiers

PMID32797198
PMCPMC7441339
OpenAlexW3049607088

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.